<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20260214068853N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-04-20</date_registration>
      <primary_sponsor>Tehran University of Medical Sciences</primary_sponsor>
      <public_title>Dry Needling and cupping therapy in Hamstring muscle</public_title>
      <acronym>CUDHAM-RCT</acronym>
      <scientific_title>Comparison of the Effects of Dry Needling and Cupping therapy on Pain Intensity, Range of Motion, and Function of the Hamstring Muscle with Active Myofascial Trigger Points in amateur athletes</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-04-20</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>30</target_size>
      <recruitment_status>Recruiting</recruitment_status>
      <url>https://irct.ir/trial/89230</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Randomization is performed using the Block Randomization method as follows to allocate participants evenly to one of the two intervention groups of dry needling plus static stretch or cupping therapy plus static stretch.
A) Randomization and allocation to groups:
Given that we have 2 groups in this study, the block size must be divisible by 2, which is the most common block size when we have 2 study groups, 4, from each block of 4 people, 2 people are placed in the dry needling group and 2 people in the cupping group.
All possible combinations for a block include AABB, ABAB, ABBA, BBAA, BABA, BAAB…. Each person enters the study based on the order in the selected block. For example, if the randomization block is AABB, the first two people will enter the dry needling group and the second two people will enter the cupping group, so that we finally have two equal groups, Blinding description: This study is single-blind, and the outcome assessor is completely blinded to the participants’ allocation to the treatment groups (dry needling or cupping therapy).

Implementation of Blinding:

Independent Assessment: Outcome assessment is conducted by an individual who has no role in the intervention delivery or participant allocation to groups.
Information Protection: Participant allocation to groups is managed by an assessor external to the research team. The outcome assessor works solely with anonymized participant codes, not group names.
Randomization Method (Blocking): To ensure group balance and prevent premature disclosure of allocation, the blocking method has been employed. In this method, blocks with specific combinations (e.g., AABB, ABAB) are defined, and participants are assigned to groups based on their order of entry into these blocks.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Hamstring Muscle with Active Myofascial Trigger Points.</hc_freetext>
      <i_freetext>Intervention group:.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Comparison of the effects of dry needling and cupping therapy on pain intensity, range of motion, and hamstring muscle function in amateur athletes.”

Data Description:

“The data includes measurements of pain intensity, range of motion, and hamstring muscle function. As no identifying information was recorded, a significant portion of the data is shareable.

When:
Six months after publication

To whom:
Academic researchers and those who are industrially involved.

Conditions:
Citation and referencing are fully permitted.

Where to obtain:
via this email address: saraslifeonig@gmail.com

How to obtain:
The requester first submits an official request, and after the initial review, assessment of ethical/legal restrictions, and final preparation of the data, the files are provided by the author.  
Depending on the type of data, the entire process typically takes between 3 and 20 working days.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Sara Delsuz</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Zarafshan street ,Abzarian , sixth Kouhsar</address>
        <city>Eslamshahr</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3314648483</zip>
        <telephone>+98 21 5635 0670</telephone>
        <email>saraslifeonig@gmail.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Sara Delsuz</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Zarafshan St. Abzarian Ave, sixth Kouhsar</address>
        <city>Eslamshahr</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3314648483</zip>
        <telephone>+98 21 5635 0670</telephone>
        <email>saraslifeonig@gmail.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients with active trigger points in the hamstring muscle (assessed by physiotherapist)
Pain intensity according to the VAS scale between 3 and 7
Amateur athletes (3 sessions per week or maximum 6 hours of weekly training for at least the last 10 months)
Individuals with hamstring muscle shortening with AKE 90/90 (physiotherapist assessment)</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>40 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Having a history of orthopedic or neurological problems in the lower extremities
Having a history of surgery in the back, hip, or knee areas
Having a recent history of hamstring strain
Having upper or lower motor neuron damage
Received treatment in the last three months
women in menstruation cycle
Having a difference in limb length of more than two centimeters
Experience of any injury to the lower extremities within the last three months</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group:</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Hamstring flexibility with active knee extension test, pain intensity with VAS or visual analogue scale, passive compliance of hamstring , peak passive torque during stretch. Timepoint: The assessment periods include one session before the start of treatment, one immediately after the first session, a third after the completion of treatment sessions, and a fourth two weeks after the assessments for follow-up. Method of measurement: Visual Analog Scale (VAS) for pain, Goniometer, Handheld dynamometer.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tehran university of medical science</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-04-10</approval_date>
        <contact_name>Ethics of commitiee of  Nursing and Midwifery ,Tehran University of Medical Sciences</contact_name>
        <contact_address>Zarafshan st. Abzarian , sixth kohsar , number nine , unite 5 Eslamshahr Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
